Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naratriptan + Naproxen FDC for Acute Migraine
NCT01726920Phase 3Withdrawn
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Jul 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of naratriptan, naproxen in migraine, sponsored by Aché Laboratórios Farmacêuticos. Planned start Jul 2014; status: withdrawn.
02
Drugs
naratriptannaproxen
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01726920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01726920.